Interestingly, the nuclear receptor estrogen receptor β (ERβ), which is considered a tumor suppressor in breast cancer, induces Claudin-6 (CLDN6)-mediated autophagic activity via directly transactivating CLDN6, thereby inhibiting the migration and invasion in breast cancer [124]. Here, ESR2 is linked to breast cancer.